Summary unavailable.

Questions

Question 1

What is the primary use for bone resorption inhibitors as described in the text?

View answer and explanation
Question 2

How do biphosphonates like alendronate and risedronate inhibit the resorption of bone?

View answer and explanation
Question 3

Which of the following conditions is a contraindication for the use of biphosphonates?

View answer and explanation
Question 4

What is the mechanism of action for the bone resorption inhibitor raloxifene?

View answer and explanation
Question 5

According to the 'Interactions' section, what effect do calcium supplements have on biphosphonates?

View answer and explanation
Question 6

For which patients is the use of raloxifene contraindicated?

View answer and explanation
Question 7

Which medication is noted to decrease the absorption of raloxifene, with concurrent use being contraindicated?

View answer and explanation
Question 8

What are the key symptoms of Paget's disease that a nurse should assess for in a patient receiving bone resorption inhibitors?

View answer and explanation
Question 9

Which laboratory test should be monitored in patients with osteoporosis who are taking bone resorption inhibitors?

View answer and explanation
Question 10

Which of the following is listed as a desired outcome for patients treated with bone resorption inhibitors for Paget's disease?

View answer and explanation
Question 11

Which class of bone resorption inhibitors includes agents like etidronate, ibandronate, and zoledronic acid?

View answer and explanation
Question 12

What patient teaching is recommended to help modify behaviors that increase the risk of osteoporosis?

View answer and explanation
Question 13

Which of the following is NOT listed as a use for bone resorption inhibitors?

View answer and explanation
Question 14

In which patient population should bone resorption inhibitors be used cautiously?

View answer and explanation
Question 15

What is the potential interaction between aspirin and biphosphonates?

View answer and explanation
Question 16

What is a key nursing assessment for patients taking bone resorption inhibitors, performed both before and periodically during therapy?

View answer and explanation
Question 17

Which laboratory value is specifically mentioned for monitoring in patients with Paget's disease taking bone resorption inhibitors?

View answer and explanation
Question 18

According to the text, raloxifene produces estrogen-like effects on bone, including which of the following?

View answer and explanation
Question 19

What is one of the potential nursing diagnoses listed for patients taking bone resorption inhibitors?

View answer and explanation
Question 20

Which of the following is listed under 'General Use' as a condition treated by bone resorption inhibitors?

View answer and explanation
Question 21

Which statement accurately reflects the information on biphosphonate contraindications?

View answer and explanation
Question 22

What is the expected outcome for a postmenopausal woman taking a bone resorption inhibitor for osteoporosis?

View answer and explanation
Question 23

Which drug is NOT listed as a biphosphonate in the provided text?

View answer and explanation
Question 24

What does the text say about the use of some bone resorption inhibitors in patients with moderate to severe renal impairment?

View answer and explanation
Question 25

Which item is NOT part of the nursing assessment for a patient with Paget's disease on bone resorption inhibitors?

View answer and explanation
Question 26

What is the general effect of biphosphonates on osteoclasts?

View answer and explanation
Question 27

A patient with a history of deep vein thrombosis should not be prescribed which bone resorption inhibitor?

View answer and explanation
Question 28

Which nursing diagnosis is associated with the patient's need for education about their medication and condition?

View answer and explanation
Question 29

What is the only medication interaction for raloxifene mentioned in the text?

View answer and explanation
Question 30

What is the general contraindication mentioned for all bone resorption inhibitors?

View answer and explanation
Question 31

What is the therapeutic goal of using bone resorption inhibitors in a patient with corticosteroid-induced osteoporosis?

View answer and explanation
Question 32

Which of these is a listed biphosphonate?

View answer and explanation
Question 33

According to the nursing implications, what assessment finding might indicate the presence of Paget's disease?

View answer and explanation
Question 34

What is the recommended patient action if they are taking biphosphonates and also need to take calcium supplements?

View answer and explanation
Question 35

The text lists 'Deficient knowledge' as a potential nursing diagnosis. What does this diagnosis relate to?

View answer and explanation
Question 36

Which behavior is encouraged as part of patient teaching to reduce osteoporosis risk?

View answer and explanation
Question 37

A key difference between biphosphonates and raloxifene is that raloxifene:

View answer and explanation
Question 38

What is the reason a patient on bone resorption inhibitors for osteoporosis should have their serum calcium monitored?

View answer and explanation
Question 39

The 'General Use' section mentions that bone resorption inhibitors are used to treat osteoporosis resulting from what specific therapy?

View answer and explanation
Question 40

What is the primary action of biphosphonates on hydroxyapatite crystals?

View answer and explanation
Question 41

Which is an appropriate nursing action based on the 'Patient/Family Teaching' section?

View answer and explanation
Question 42

Raloxifene is contraindicated in women of reproductive potential for what reason?

View answer and explanation
Question 43

What is the primary evaluation outcome for a patient taking a bone resorption inhibitor for osteoporosis?

View answer and explanation
Question 44

Which symptom of Paget's disease involves the senses?

View answer and explanation
Question 45

The text implies that when using bone resorption inhibitors in patients with renal impairment, caution is needed because:

View answer and explanation
Question 46

If a patient taking a biphosphonate also takes aspirin, what potential issue should the nurse monitor for?

View answer and explanation
Question 47

What is the only instruction for 'Implementation' provided in the nursing implications section?

View answer and explanation
Question 48

Which statement best describes the 'General Action and Information' about bone resorption inhibitors?

View answer and explanation
Question 49

A patient with osteoporosis is prescribed a biphosphonate. Which assessment is crucial before starting the therapy?

View answer and explanation
Question 50

What is the relationship between cholestyramine and raloxifene?

View answer and explanation

Other chapters